|
1
|
Wright AA, Howitt BE, Myers AP, Dahlberg
SE, Palescandolo E, Van Hummelen P, MacConaill LE, Shoni M, Wagle
N, Jones RT, et al: Oncogenic mutations in cervical cancer: Genomic
differences between adenocarcinomas and squamous cell carcinomas of
the cervix. Cancer. 119:3776–3783. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Koh WJ, Greer BE, Abu-Rustum NR, Apte SM,
Campos SM, Chan J, Cho KR, Cohn D, Crispens MA, DuPont N, et al:
National Comprehensive Cancer Network: Cervical cancer. J Natl
Compr Canc Netw. 11:320–343. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Torre LA, Siegel RL, Ward EM and Jemal A:
Global cancer incidence and mortality rates and trends - An update.
Cancer Epidemiol Biomarkers Prev. 25:16–27. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Fedewa SA, Miller KD,
Goding-Sauer A, Pinheiro PS, Martinez-Tyson D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2015. CA Cancer J Clin.
65:457–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fulda S and Debatin KM: Extrinsic versus
intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene.
25:4798–4811. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fulda S and Debatin KM: Sensitization for
anticancer drug-induced apoptosis by the chemopreventive agent
resveratrol. Oncogene. 23:6702–6711. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Green DR and Kroemer G: The
pathophysiology of mitochondrial cell death. Science. 305:626–629.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashkenazi A: Targeting death and decoy
receptors of the tumour-necrosis factor superfamily. Nat Rev
Cancer. 2:420–430. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen J, Solomides C, Parekh H, Simpkins F
and Simpkins H: Cisplatin resistance in human cervical, ovarian and
lung cancer cells. Cancer Chemother Pharmacol. 75:1217–1227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen Y, Wang P, Li Y, Ye F, Wang F, Wan X,
Cheng X, Lu W and Xie X: miR-375 is upregulated in acquired
paclitaxel resistance in cervical cancer. Br J Cancer. 109:92–99.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang C, Dong J, Zhang Y, Wang F, Gao H, Li
P, Wang S and Zhang J: Design, synthesis and biological evaluation
of biphenyl urea derivatives as novel VEGFR-2 inhibitors. Bioorg
Med Chem. 4:1434–1438. 2013.
|
|
14
|
Li Y and He L: Establishment of the model
of vascular endothelial cell membrane chromatography and its
preliminary application. Chin Sci Bull. 52:922–928. 2007.
View Article : Google Scholar
|
|
15
|
Zhan Y, Zhang Y, Chen Y, Wang N, Zheng L
and He L: Activity of taspine isolated from Radix et Rhizoma
Leonticis against estrogen-receptor-positive breast cancer.
Fitoterapia. 82:896–902. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, He L, Meng L and Luo W: Taspine
isolated from Radix et Rhizoma Leonticis inhibits proliferation and
migration of endothelial cells as well as chicken chorioallantoic
membrane neovascularisation. Vascul Pharmacol. 48:129–137. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhan Y, Zhang H, Li J, Zhang Y, Zhang J
and He L: A novel biphenyl urea derivate inhibits the invasion of
breast cancer through the modulation of CXCR4. J Cell Mol Med.
19:1614–1623. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Malumbres M, Harlow E, Hunt T, Hunter T,
Lahti JM, Manning G, Morgan DO, Tsai LH and Wolgemuth DJ:
Cyclin-dependent kinases: A family portrait. Nat Cell Biol.
11:1275–1276. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Casagrande F and Darbon JM: Effects of
structurally related flavonoids on cell cycle progression of human
melanoma cells: Regulation of cyclin-dependent kinases CDK2 and
CDK1. Biochem Pharmacol. 61:1205–1215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Pagano M, Pepperkok R, Verde F, Ansorge W
and Draetta G: Cyclin A is required at two points in the human cell
cycle. EMBO J. 11:961–971. 1992.PubMed/NCBI
|
|
24
|
Houston A and O'Connell J: The Fas
signalling pathway and its role in the pathogenesis of cancer. Curr
Opin Pharmacol. 4:321–326. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee EW, Kim JH, Ahn YH, Seo J, Ko A, Jeong
M, Kim SJ, Ro JY, Park KM, Lee HW, et al: Ubiquitination and
degradation of the FADD adaptor protein regulate death
receptor-mediated apoptosis and necroptosis. Nat Commun. 3:9782012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kaufmann SH and Earnshaw WC: Induction of
apoptosis by cancer chemotherapy. Exp Cell Res. 256:42–49. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ghobrial IM, Witzig TE and Adjei AA:
Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin.
55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ashkenazi A: Targeting the extrinsic
apoptosis pathway in cancer. Cytokine Growth Factor Rev.
19:325–331. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tsujimoto Y: Cell death regulation by the
Bcl-2 protein family in the mitochondria. J Cell Physiol.
195:158–167. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hunter AM, LaCasse EC and Korneluk RG: The
inhibitors of apoptosis (IAPs) as cancer targets. Apoptosis.
12:1543–1568. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zou H, Henzel WJ, Liu X, Lutschg A and
Wang X: Apaf-1, a human protein homologous to C. elegans
CED-4, participates in cytochrome c-dependent activation of
caspase-3. Cell. 90:405–413. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fridman JS and Lowe SW: Control of
apoptosis by p53. Oncogene. 22:9030–9040. 2003. View Article : Google Scholar : PubMed/NCBI
|
